Nonopportunistic Neurologic Manifestations of the Human Immunodeficiency Virus: An Indian Study

Table 9 Cases of Guillain-Barré Syndrome (n = 8)

Clinical features	Age/Sex	CD4+ Cell Count(cells/mcL)	Type of GBS	Therapy	Status
Ascending paraparesis	23 y/M	335	AIDP	IVIG	Improved
Quadriplegia requiring ventilator	30 y/M	420	AIDP	IVIG	Improved
Ascending weakness with neck muscle involvement	45 y/M	450	AMAN	Steroids	Improved
Quadriplegia	35 y/M	204	AMSAN	Nil	Mild improvement
Descending weakness with lower cranial nerve palsies	34 y/M	195	AMSAN	Nil	Mild improvement
Quadriparesis	33 y/M	456	AIDP	Steroids	Improved
Ascending muscle weakness	35 y/F	400	AMAN	IVIG	Mild improvement
Paraparesis	42 y/M	450	AIDP	Nil	Not available

GBS = Guillain-Barré syndrome; IVIG = intravenous immunoglobulin; AIDP = acute inflammatory demyelinating polyradiculoneuropathy; AMAN = acute motor axonal neuropathy; AMSAN = acute motor and sensory axonal neuropathy